“Prescription” means:

I. An order given individually for the person for whom prescribed, directly from the practitioner, or the practitioner’s agent, to a pharmacist.
II. A chart order written for an inpatient specifying drugs which he or she is to take home upon discharge.
III. A chart order written for an inpatient for use while he or she is an inpatient.

a. I only
b. I and II only
c. II and III only
d. All

Answer:

“Prescription” means:

I. An order given individually for the person for whom prescribed, directly from the practitioner, or the practitioner’s agent, to a pharmacist.
II. A chart order written for an inpatient specifying drugs which he or she is to take home upon discharge.
III. A chart order written for an inpatient for use while he or she is an inpatient.

a. I only
b. I and II only
c. II and III only
d. All

Answer: (b). 1. "Prescription" means:

(a). An order given individually for the person for whom prescribed, directly from the practitioner, or the practitioner's agent, to a pharmacist or indirectly by means of an order signed by the practitioner or an electronic transmission from the practitioner to a pharmacist.

(b). A chart order written for an inpatient specifying drugs which he or she is to take home upon discharge.

2. "Prescription" does not include a chart order written for an inpatient for use while he or she is an inpatient.

“Marijuana” means:

I. The seeds of plant of the genus Cannabis.
II. The resin extracted from plant of the genus Cannabis.
III. The mature stems of the plant of the genus Cannabis.

a. I only
b. I and II only
c. II and III only
d. All

Answer:

“Marijuana” means:

I. The seeds of plant of the genus Cannabis.
II. The resin extracted from plant of the genus Cannabis.
III. The mature stems of the plant of the genus Cannabis.

a. I only
b. I and II only
c. II and III only
d. All

Answer: (b) I and II only, [Nevada Revised Statues 453.096].

"Marijuana" means:

(a). All parts of any plant of the genus Cannabis, whether growing or not;
(b). The seeds thereof;
(c). The resin extracted from any part of the plant; and
(d). Every compound, manufacture, salt, derivative, mixture or preparation of the plant, its seeds or resin.

2. "Marijuana" does not include the mature stems of the plant, fiber produced from the stems, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture or preparation of the mature stems (except the resin extracted therefrom), fiber, oil or cake, or the sterilized seed of the plant which is incapable of germination.

If the managing pharmacist is the only registered pharmacist employed in the pharmacy, the Board may authorize his or her absence each day for a total period of not to exceed 2 hours for the purpose of taking meals if:

I. A registered pharmacist is on call during the absence.
II. A sign is posted for public view in the pharmacy indicating the absence of the pharmacist and the hours of the absence.
III. The authorization required from the Board must be in writing and be retained in the pharmacy and available for inspection.

a. I only
b. I and II only
c. II and III only
d. All

Answer:

If the managing pharmacist is the only registered pharmacist employed in the pharmacy, the Board may authorize his or her absence each day for a total period of not to exceed 2 hours for the purpose of taking meals if:

I. A registered pharmacist is on call during the absence.
II. A sign is posted for public view in the pharmacy indicating the absence of the pharmacist and the hours of the absence.
III. The authorization required from the Board must be in writing and be retained in the pharmacy and available for inspection.

a. I only
b. I and II only
c. II and III only
d. All

Answer: (d) All, [Nevada Revised Statues 639.220(2)].

If the managing pharmacist is the only registered pharmacist employed in the pharmacy, the Board may authorize his or her absence each day for a total period of not to exceed 2 hours for the purpose of taking meals if:

a. A registered pharmacist is on call during the absence.

b. A sign is posted for public view in the pharmacy indicating the absence of the pharmacist and the hours of the absence.

c. All drugs, poisons, chemical and restricted devices are kept safe in a manner prescribed by regulations of the Board.

d. The authorization required from the Board must be in writing and be retained in the pharmacy and available for inspection.

ISMP has developed a tool to help address the reasons why barcode scanning has not been implemented and to facilitate the adoption of this technology in community pharmacies that do not currently utilize it for product verification. This tool is known as a(n):

a. PBSSD
b. CDQRP
c. ABVSR
d. QURPS

Answer:

ISMP has developed a tool to help address the reasons why barcode scanning has not been implemented and to facilitate the adoption of this technology in community pharmacies that do not currently utilize it for product verification. This tool is known as a(n):

a. PBSSD
b. CDQRP
c. ABVSR
d. QURPS

Answer:(c). Barcoding technology is well-established in industries outside of the health care sector and is now being used within health care to enhance efficiency and safety, and in pharmaceutical wholesale operations to improve supply chain inventory and efficiency.

According to a survey conducted by ISMP in 2009, the most frequently reported reasons for implementing barcode scanning for product verification included a desire to improve the accuracy and safety of the dispensing process, the ease with which the technology fits with pharmacy workflow, improvement of staff efficiency and inventory control, and a belief that the technology was necessary to stay in business.

The most common reasons for not implementing barcode scanning for product verification, other than cost, included uncertainty regarding the "right" vendor product, satisfaction with the current system (without barcode product verification), and perceptions that the technology would reduce staff efficiency.

ISMP has developed a tool, Assessing Barcode Verification System Readiness in Community Pharmacies, to help address the reasons why barcode scanning has not been implemented and to facilitate the adoption of this technology in an estimated 27,327 community pharmacies that do not currently utilize it for product verification.

An Expungement means that: 

I. The affected records shall be sealed.
II. The proceedings to which they refer shall be deemed not to have occurred.
III. The affected party may properly represent that no record exists regarding the matter expunged.

a.I only
b. I and II only
c. II and III only
d. All

Answer:

An Expungement means that: 

I. The affected records shall be sealed.
II. The proceedings to which they refer shall be deemed not to have occurred.
III. The affected party may properly represent that no record exists regarding the matter expunged.

a. I only
b. I and II only
c. II and III only
d. All

Answer: All. In the common law legal system, an expungement proceeding is a type of lawsuit in which a first time offender of a prior criminal conviction seeks that the records of that earlier process be sealed, thereby making the records unavailable through the state or Federal repositories.

If successful, the records are said to be "expunged". Black's Law Dictionary defines "expungement of record" as the "Process by which record of criminal conviction is destroyed or sealed from the state or Federal repository." While expungement deals with an underlying criminal record, it is a civil action in which the subject is the petitioner or plaintiff asking a court to declare that the records be expunged.

A very real distinction exists between an expungement and a pardon. When an expungement is granted, the person whose record is expunged may, for most purposes, treat the event as if it never occurred.

A pardon (also called "executive clemency") does not "erase" the event; rather, it constitutes forgiveness.

In the United States, an expungement can be granted only by a judge; while a pardon can be granted only by the President of the United States for federal offenses, and the state governor, certain other state executive officers, or the State Board of Pardons and Paroles (varies from state to state) for state offenses.

Prior to prescribing, administering, dispensing, ordering, selling, supplying, or giving a Schedule III or IV amphetamine-like controlled substance to treat obesity in a patient sixteen (16) years of age or older, the physician shall obtain and review:

a. JNC Obesity Guidelines
b. CDCP Report
c. KASPER Report
d. DNPAO Guidelines

Answer:

Prior to prescribing, administering, dispensing, ordering, selling, supplying, or giving a Schedule III or IV amphetamine-like controlled substance to treat obesity in a patient sixteen (16) years of age or older, the physician shall obtain and review:

a. JNC Obesity Guidelines
b. CDCP Report
c. KASPER Report
d. DNPAO Guidelines

Answer:(c). Kentucky All Schedule Prescription Drug Electronic Reporting System (KASPER) report, [201 KAR 9:016 Section 4].

(1). Prior to prescribing, administering, dispensing, ordering, selling, supplying, or giving a Schedule III or IV amphetamine-like controlled substance to treat obesity in a patient sixteen (16) years of age or older, the physician shall:

(a). Establish a physician/patient relationship;

(b). Determine that the patient is obese or overweight with medical risk factors and is a proper candidate for weight reduction treatment;

(c). Determine and record the extent of prior anorectics or other controlled substances used by the patient.

The prescribing physician shall obtain and review a KASPER report for the twelve (12) month period immediately preceding the patient encounter, before prescribing or dispensing controlled substances to the patient.

(2). During treatment for obesity, a physician shall:

(a). Maintain a physician/patient relationship throughout the treatment process;

(b). Maintain an adequate patient record in accordance with subsection (4) of this section; and

(c). Justify in the patient record the use of any Schedule III or IV amphetamine-like controlled substance beyond three (3) months.

Before the physician continues the use of a substance beyond three (3) months, the physician shall obtain and review a current KASPER report.

The board may suspend the pharmacist license if a licensee fails to notify the board within 14 days of a change in one's home address.

Answer: True or False

The board may suspend the pharmacist license if a licensee fails to notify the board within 14 days of a change in one's home address.

Answer: True, [Kentucky Revised Statues, Chapter 315, 315.121(k)].

The board may refuse to issue or renew a license, permit, or certificate to, or may suspend, temporarily suspend, revoke, fine, place on probation, reprimand, reasonably restrict, or take any combination of these actions against any licensee, permit holder, or certificate holder for the following reasons:

(k). Failure to notify the board within fourteen (14) days of a change in one's home address.

What is the principal side effect of Acarbose (Precose)?

a. Hyperglycemia
b. Bloating and diarrhea
c. Severe constipation
d. Bleeding

Answer:

What is the principal side effect of Acarbose (Precose)?

a. Hyperglycemia
b. Bloating and diarrhea
c. Severe constipation
d. Bleeding

Answer: b. Acarbose (Precose) is an oral alpha-glucosidase inhibitor for use in the management of type 2 diabetes mellitus. It delays the digestion of ingested carbohydrates, thereby resulting in a smaller rise in blood glucose concentration following meals. As a consequence of plasma glucose reduction, Precose reduces levels of glycosylated hemoglobin in patients with type 2 diabetes mellitus.

The recommended starting dosage of Acarbose (Precose) is 25 mg given orally three times daily at the start (with the first bite) of each main meal . However, some patients may benefit from more gradual dose titration to minimize gastrointestinal side effects. This may be achieved by initiating treatment at 25 mg once per day and subsequently increasing the frequency of administration to achieve 25 mg t.i.d.

Hypoglycemia, gas, bloating and diarrhea are commonly reported side effects of Acarbose (Precose).

According to DC Pharmacy Law, a health care facility may dispose of any pharmaceutical product, used or unused, by flushing the product down a drain.

True or False

According to DC Pharmacy Law, a health care facility may dispose of any pharmaceutical product, used or unused, by flushing the product down a drain.

Answer: False, [DC Official Code Title 22B Chapter 5 Section 500.1 and 500.2 ].

Effective July 1, 2013, unless authorized by this chapter, a health care facility that is determined to have disposed of a pharmaceutical product by flushing the product down a drain or by any other method that utilizes the public sewer system, shall be:  

(a). Subject to a civil fine of up to one thousand dollars ($1,000) per occurrence; and  

(b). Required to submit to the Board of Pharmacy, or its designee, a mitigation plan designed to prevent further such occurrences within thirty (30) days of receipt of a request for the mitigation plan. 

At the time the pharmacist manager in whose name the registration was obtained ceases to be employed as the pharmacist manager, he or she shall report to the board within 30 days the fact that he or she is no longer manager of the prescription drug outlet.

At the time the pharmacist manager in whose name the registration was obtained ceases to be employed as the pharmacist manager, he or she shall report to the board within 30 days the fact that he or she is no longer manager of the prescription drug outlet.

Answer: False, [Colorado Revised Statutes Ttile 12 Article 42.5 Section 12-42.5-116].

(1). (a). A prescription drug outlet must be under the direct charge of a pharmacist manager. A proprietor who is not a pharmacist shall comply with this requirement and shall provide a manager who is a pharmacist.

(b). The registration of any prescription drug outlet becomes void if the pharmacist manager in whose name the prescription drug outlet registration was issued ceases to be engaged as the manager. The owner shall close the prescription drug outlet unless the owner:

(I). Employs a new pharmacist manager; and

(II). Within thirty days after termination of the former manager's employment:

(A). Applies to transfer the registration to the new pharmacist manager; and

(B). Pays the registration transfer fee.

(c). At the time the pharmacist manager in whose name the registration was obtained ceases to be employed as the pharmacist manager, he or she shall IMMEDIATELY (Not within 30 days) report to the board the fact that he or she is no longer manager of the prescription drug outlet.

The pharmacist manager is responsible as the manager until the cessation of employment is reported. The proprietor of the prescription drug outlet shall also notify the board of the termination of managership.